ロード中...
Aflibercept for the Treatment of Age-Related Macular Degeneration
Aflibercept is a novel, recombinant, fusion protein that consists of portions of vascular endothelial growth factor (VEGF) receptor (R) 1 and VEGFR2 extracellular domains fused to the Fc portion of human immunoglobulin G1. It exhibits higher affinity for VEGF-A/-B and binds all the VEGF isoforms (VE...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Healthcare
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4108145/ https://ncbi.nlm.nih.gov/pubmed/25135809 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40123-013-0015-2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|